Clinical Trial

Transthoracic Echocardiography in Assessing Patients With Suspected Endocarditis

Study acronym: TEASE-Forward
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This single-center, prospective observational study evaluates the accuracy of transthoracic echocardiography (TTE) to rule out infective endocarditis (IE) in patients with suspected IE, with the goal of reducing unnecessary transesophageal echocardiography (TOE), a more invasive diagnostic test. Eligible patients are those admitted to the Department of Cardiovascular Sciences at Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Rome, Italy) who undergo TOE for suspected IE within 15 days of a TTE. Clinical, laboratory, and echocardiographic variables will be collected to characterize the study population and support analyses of diagnostic performance and in-hospital outcomes.
Trial Details
NCT Number NCT07415369
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Endocarditis Infective
Enrollment 350 participants
Start Date 2026-03
Primary Completion 2027-03 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-17